Introduction
Gonococcal urethritis is a common clinical presentation in men presenting to primary health care clinics and private medical general practitioners in Southern Africa. In public health care clinics and in many private medical practices, treatment for sexually transmitted infections is reliant on syndromic management. 1 For successful syndromic management, constant monitoring of the antimicrobial susceptibility of the causative organisms is required.
Penicillin was the antibiotic of choice for the treatment of gonorrhoea up to the early 1980s in South Africa. Thereafter, the emergence of penicillinase-producing Neisseria gonorrhoeae (PPNG) and chromosomally mediated resistance to penicillin (CMRNG), as well as tetracycline resistance, prompted the use of alternative treatment regimens for urethritis. 2 The mechanism of resistance of N. gonorrhoeae to penicillin and tetracycline resulted in the profiling of the plasmids that revealed the presence of the 4.4 MDa ('Asian') plasmids and the 3.2 MDa ('African') plasmids, as well as high-level tetracycline-resistant plasmid carrying the 'American type' TetM gene. [3] [4] [5] In view of the ongoing resistance of the gonococcal isolates to penicillin and tetracycline, the national Department of Health of South Africa advocated the use of ciprofloxacin (500 mg stat dose) as first-line therapy for uncomplicated gonococcal urethritis as part of syndromic management in 1996. 1 Subsequent antimicrobial surveillance of gonococcal isolates from various centres in South Africa indicated that the isolates were susceptible to ciprofloxacin. [6] [7] More recently, the first ciprofloxacin-resistant N. gonorrhoeae isolates were detected in KwaZulu-Natal. 8 Subsequent to the KwaZulu-Natal publication, there were reports of quinolone resistance from other centres in South Africa. 9 We describe the antimicrobial susceptibilities and plasmid profiles of gonococcal isolates isolated in Pretoria, South Africa, over a 20-year period .
Materials and methods

Patients
Aetiological surveys (published and unpublished) for acute urethritis were conducted by the Department of Microbiological Pathology at the then Medical University of Southern Africa in Pretoria in 1984, 10 1991, 11 1992 and 2004. 12 The patients were men attending the primary health care clinics and private medical practitioners in the city of Pretoria.
Specimen collection and isolation of Neisseria gonorrhoeae
Endourethral swabs were taken from men with complaints of burning on micturition and/or having urethral discharge. The swabs were inoculated onto modified New York City media at the bedside or placed into Amies' charcoal transport media and transported to the laboratory, where they were subsequently plated out onto the Thayer Martin medium and, in the more recent studies, onto New York City medium. Plates were incubated at 35ºC in a humidified atmosphere of 5-10% CO 2 for 48 hours. Isolates were identified as N. gonorrhoeae by Gram-staining, oxidase reaction and by their ability to produce acid from glucose, but not from maltose or sucrose.
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Antimicrobial susceptibility testing
All gonococcal isolates were tested for penicillinase production using the chromogenic cephalosporin, nitrocephin (Oxoid). Antibiotic susceptibility testing of the gonococcal isolates was carried out using the Kirby Bauer disc diffusion method on GC agar base (Oxoid, UK) supplemented with 1% IsoVitaleX. The diameter of the inhibition zone was measured in millimetres and interpreted according to National Committee for Clinical Laboratory Standards (CLSI) criteria. 13 The minimum inhibitory concentration (MIC) of ciprofloxacin for N. gonorrhoeae strains was determined by the Etest ® (AB Biodisk) on GC medium enriched with 1% IsoVitaleX. For both the methods, an inoculum density of 0.5 MacFarland's standard was used. The standard agar dilution method was used to determine the MICs of penicillin, cefoxitin, ceftriaxone, cefpodoxime, tetracycline, ciprofloxacin, ofloxacin and spectinomycin. One microlitre volumes containing 10 4 cfu were inoculated onto media containing appropriate dilutions of the antibiotic under test in GC agar base (Oxoid, UK) supplemented with 1% IsoVitaleX. 
Tetracycline-resistant Neisseria gonorrhoeae (TRNG)
TRNG strains were screened by growth on GC agar medium containing 10 mg/l tetracycline for 24 h. Growths of N. gonorrhoeae on this medium indicated high-level resistance and were designated as TRNG; this was confirmed with polymerase chain reaction (PCR). 4 
Plasmid analysis
Plasmids were extracted from PPNG strains using the rapid alkaline lysis method of Birnboim and Doly 14 and separated by electrophoresis in 1% agarose gel. Plasmids were visualised by ultraviolet light transillumination of ethidium bromide-stained gels.
Results
The prevalence of PPNG and CMRNG strains in the four surveys undertaken is shown in Table 1 . PPNG strains had increased from 4% in 1984 to 16% in 2004, whilst the CMRNG (≥2 mg/l) strains have also increased dramatically, from 0% in 1984 to 16% in 2004. However, in 1991, the MICs were not determined.
The susceptibility profiles of the most recent gonococcal isolates (2004) in the city of Pretoria are shown in Table 2 . Nineteen of the 119 non-PPNG isolates (16%) were considered totally resistant (CMRNG ≥2 mg/l) to penicillin. Decreased susceptibility (MIC 0.125-1 mg/l) was detected in 73% of the isolates. Resistance to tetracycline (MIC ≥2 mg/l) has increased from 7% in 1992 to 54% in 2004. Only 46 (33%) isolates remained susceptible to tetracycline, while 13% showed intermediate resistance to tetracycline. Low level resistance was detected in 18% of the isolates. There was a dramatic increase of high-level tetracycline resistance (TRNG; MIC ≥ 16 mg/l) strains from 0% in 1992 to 36% in 2004.
All high-level tetracycline-resistant gonococcal isolates (MIC ≥16 mg/l) were identified as TRNG in the 2004 study by growth on the gonococcal sensitivity medium containing 10 mg/l tetracycline and confirmed by the presence of the TetM gene by PCR.
Ciprofloxacin resistance (MIC ≥1 mg/l) was detected for the first time in 2004. Resistance was detected in 7% of strains; having MIC values ≥1 mg/l. Ninety-three percent (131/141) remained fully sensitive whilst no isolates showed decreased susceptibility to the agent, i.e. MIC values were very low.
As reported in the study of 2004, 12 all isolates remained susceptible to cefoxitin, ceftriaxone, cefpodoxime and spectinomycin. Ceftriaxone proved to be the most active agent with MIC 90 values of 0.004 mg/l. Original Research: Antimicrobial susceptibility patterns of gonococcal isolates Thirty-six of the 141 (26%) isolates had MIC values of 64 mg/l for spectinomycin, i.e. only one dilution away from the cut off for resistance ( Table 3 ).
The distribution of penicillin, cefoxitin, ceftriaxone, cefpodoxime, spectinomycin, ciprofloxacin and ofloxacin MICs among 51 TRNG and 90 non-TRNG is shown in Table 3 . Twenty TRNG (39%) and 11 non-TRNG (12%) produced ß-lactamase (PPNG ≥4 mg/l); six TRNG (12%) and two non-TRNG (2%) were chromosomally resistant to penicillin (CMRNG ≥2 mg/l); 25 TRNG (49%) and 63 non-TRNG (70%) were of intermediate resistance to penicillin (0.125-1 mg/l), and no TRNG and 14 (16%) non-TRNG were fully susceptible to penicillin (≤0.06 mg/l). All isolates were susceptible to cefoxitin (MIC ≤2 mg/l), ceftriaxone (MIC ≤0.25 mg/l), cefpodoxime (MIC ≤0.25 mg/l) and spectinomycin (MIC ≤6 4mg/l). Ten (20%) TRNG were resistant to both ciprofloxacin and ofloxacin.
The plasmid profile for the PPNG isolates obtained in 2004 is shown in Table 4 . There was an equal distribution of the 3.2 MDa and 4.4 MDa plasmids. All PPNG strains were found to carry the 2.6 MDa cryptic plasmid. The 25.2 MDa TetM plasmid was present in 11% of PPNG strains.
Discussion
In view of the ongoing resistance of the gonococcal isolates to penicillin and tetracycline, the South African Department of Health advocated ciprofloxacin (500 mg stat dose) as first-line therapy for uncomplicated gonococcal urethritis as part of syndromic management in 1996.
1 During this period, quinolone-resistant gonococci (QRNG) with MICs ≥1 mg/l isolates to ciprofloxacin had been reported from different parts of the world, notably the Far East, South-East Asia, Australia, UK and USA. 15, 16 Antimicrobial surveillance of gonococcal isolates from various centres in South Africa indicated that the isolates were susceptible to ciprofloxacin. 6, 7 More recently, the first ciprofloxacin-resistant N. gonorrhoeae isolates were detected in KwaZulu-Natal. 8 Subsequent to the KwaZulu-Natal publication, there were reports of quinolone resistance from other centres in South Africa. there is potential for these plasmids to continue spreading. Higher rates of tetracycline resistance (CMTRNG) (29%-45%) have been documented in KwaZulu-Natal. 
